The type of anti-inflammatory medication used post selective laser trabeculoplasty (SLT) may have an impact on the intra-ocular pressure (IOP) lowering effect of SLT. This study will evaluate the IOP lowering effect of SLT following the topical administration of one of the following: prednisolone 1%, ketorolac 0.5% or artificial tears.
Patients who have been chosen to undergo SLT for glaucoma will be randomized to receive one of prednisolone 1%, ketorolac 0.5% or artificial tears four times a day for 5 days following administration of the laser treatment. The IOP will be measured at various time points following SLT: 1 hour, 2 days, 1 week, 1 month, 3 months, 6 months, and 1 year.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
120
eye drop once in each eye treated, 4 times / day for 5 days post-laser
eye drop once in each eye treated, 4 times / day for 5 days post-laser
eye drop once in each eye treated, 4 times / day for 5 days post-laser
Queen's University
Kingston, Ontario, Canada
Intraocular pressure lowering effect
Time frame: 1 hour, 2 days, 1 month, 3 months, 6 months and 1 year
intraocular pressure elevation
Time frame: 1 hour, 2 days, 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.